drugset / Trial / NCT02139618
Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage
Phase 2
Completed
60 enrolled
Fundación Dermabase
Grupo de Investigacion Dermatologica (GRID) · collabIPS Universitaria-Universidad de Antioquia · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Treatment of actinic damage has included multiple procedures but to date there is limited scientific evidence to support the preferential use of one of these therapies according to their efficacy, safety and pain tolerance by patients. This study aims to assess the efficacy of methyl aminolevulinate + daylight vs placebo + daylight to treat facial photodamage
Timeline
- Start
- 2014-04
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | methyl aminolevulinate | Small molecule | 1 g | Topical |